Fresenius SE and Co KGaA (FRE) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes machines for hemodialysis, acute dialysis and peritoneal dialysis; solutions for infusion therapy; dialysis care services; Spectra laboratories; liver support therapy services; and provision projects and services for hospitals and other health care facilities. It also operates and manages acute care and postacute care hospitals in Germany through Helios Kliniken Group. Its major manufacturing plants are in the US, Germany, China, Sweden and Japan. Fresenius conducts operations in Asia-Pacific, Europe, Africa and the Americas. The company is headquartered in Bad Homburg, Hessen, Germany.

Fresenius SE & Co KGaA (FRE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 6
List of Figures 7
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11
Fresenius SE & Co KGaA, Medical Devices Deals, 2012 to YTD 2018 12
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deal Details 17
Asset Purchase 17
Fresenius Acquires Biosimilars Business from Merck for USD703 Million 17
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 19
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 20
Sound Inpatient Physicians Acquires Certain Assets from Inpatient Specialists 21
Fresenius Completes Acquisition Of 38 Hospitals And 11 Outpatient Facilities From Rhon-Klinikum 22
Sound Inpatient Physicians Acquires Certain Assets Of Inpatient Care Unified 24
Fresenius Kabi India To Acquire Manufacturing Unit Of Goa Formulations For US$37 Million 25
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 26
Venture Financing 27
Fresenius Medical Care Elgin Raises US$3 Million In Venture Financing 27
Fresenius Medical Care Palatine Raises US$3 Million In Venture Financing 28
Fresenius Medical Care Raises US$5.5 Million In Venture Financing 29
Fresenius Vascular Care Raises US$0.3 Million In Venture Financing 30
Noro-Moseley Partners Acquires Minority Stake In Diabetes Care Group From Renal Care Group 31
Fresenius Medical Care Batavia Raises US$1.8 Million In Venture Financing 32
Fresenius Medical Care West Raises US$2.3 Million In Venture Financing 33
Fresenius Medical Care Enid Raises US$2.4 Million In Venture Financing 34
Partnerships 35
Spectral Medical Enters into Agreement with Fresenius Medical Care Deutschland 35
CytoSorbents Expands its Distribution Agreement with Fresenius Medical Care for CytoSorb Therapy 36
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 37
Otsuka Pharma Factory Enters Into Distribution Agreement With Fresenius Kabi Japan For HES Products 38
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 39
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 40
Provepharm Enters Into Distribution Agreement With Fresenius Kabi Pharma 41
Huons Enters Into Co-Promotion Agreement With Fresenius Kabi For Fresofol 42
Licensing Agreements 43
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 43
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 44
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 45
Toray Industries Enters Into Licensing Agreement With Fresenius Medical Care For TRK-820 46
Equity Offering 47
Humacyte to Raise USD150 Million in Equity Financing 47
Fresenius Plans Private Placement Of Shares For US$1.3 Billion 48
Debt Offering 49
Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 49
Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 50
Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 51
Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 52
Fresenius Raises USD300 Million in Private Placement of Notes 53
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 54
Fresenius Increases Size Of Private Placement Of Notes Due 2024 For US$611.4 Million 55
Fresenius Completes Private Placement Of Notes Due 2019 For US$407.6 Million 56
Fresenius Completes Private Placement Of Notes Due 2021 For US$611.4 Million 57
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 58
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 60
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 61
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 62
Asset Transactions 63
Xellia Acquires Lyophilized Manufacturing Facility from Fresenius Kabi 63
Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 64
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 65
Acquisition 66
NewCo Pharma Acquires CFL from Fresenius Kabi 66
Sound Physicians Acquires Cogent Healthcare 67
Fresenius Medical Care Acquires National Cardiovascular 68
Fresenius Kabi Acquires Novafarma Industria Farmaceutica 69
Berenberg Acquires 5% Stake in Rhoen-Klinikum from Fresenius 70
Fresenius Medical Care Acquires MedSpring Urgent Care 72
Fresenius Medical Care to Acquire Majority Stake in Sound Inpatient Physicians for USD600 Million 73
Fresenius Kabi Acquires 51% Stake in Ethica Industri Farmasi From Soho Global Halthcare 74
Neopharm Acquires Biotech Arm Of Fresenius 75
Fresenius Kabi (Singapore) To Delist Its Indian Arm 77
Linde To Acquire Calea France From Fresenius Kabi 78
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 79
Fresenius Acquires 70% Stake In Huangshi Lishizhen Medicine Group Wuhan Xisu Pharma From Huangshi Lishizhen Medicine Group Wuhan Lishizhen Medicine 81
Fresenius Kabi Plans To Sell 15% Stake In Fresenius Kabi Oncology 82
Fresenius Medical Care Completes Acquisition Of Liberty Dialysis Holdings For US$1.7 Billion 83
Fresenius Medical Care Acquires Eastview Dialysis 85
Fresenius SE & Co KGaA - Key Competitors 86
Fresenius SE & Co KGaA - Key Employees 87
Fresenius SE & Co KGaA - Locations And Subsidiaries 88
Head Office 88
Other Locations & Subsidiaries 88
Recent Developments 91
Strategy And Business Planning 91
Jun 27, 2018: Fresenius Kabi expanding operations at UK site 91
May 09, 2018: Fresenius holds topping-out ceremony for new EK3 building at headquarters in Bad Homburg 92
Mar 22, 2018: Fresenius starts work on new RD building in Bad Homburg 93
Oct 19, 2017: Fresenius Vamed opens Institute for Gender Medicine 94
Jun 08, 2017: Fresenius Medical Care sees excellent prospects for further growth and launches a new Global Efficiency Program at its Capital Markets Day 2017 95
Financial Announcements 96
May 03, 2018: Fresenius makes excellent start to 2018, with strong sales and net income growth in constant currency 96
May 03, 2018: Fresenius Medical Care remains on track for another record year after solid first quarter 2018 101
Feb 26, 2018: Fresenius remains on growth course after 14 straight record years 105
Aug 01, 2017: Fresenius confirms its guidance after a strong second quarter with double-digit sales and earnings growth 112
May 03, 2017: Fresenius is off to an excellent start to the year with strong sales and earnings growth 115
Feb 22, 2017: Fresenius reports 13th consecutive record year and targets continued strong growth 121
Corporate Communications 126
May 02, 2018: Fresenius Medical Care Announces Leadership Change in EMEA 126
Jul 21, 2017: Fresenius appoints Rachel Empey as Chief Financial Officer 127
Jan 13, 2017: Fresenius Medical Care Announces Leadership Change in North America 128
Legal and Regulatory 129
Jan 31, 2017: Fresenius Medical Care reaches agreement on outstanding payments 129
Jan 26, 2017: U.S. District Court Issues Preliminary Injunction Against Premium Assistance Regulation 130
Other Significant Developments 131
May 17, 2018: Fresenius Medical Care forecasts continued strong growth 131
Aug 22, 2017: Fresenius Helios invests in German hospital network 132
Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule 133
Appendix 134
Methodology 134
About GlobalData 134
Contact Us 134
Disclaimer 134

List Of Tables

List of Tables
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10
Fresenius SE & Co KGaA, Deals By Therapy Area, 2012 to YTD 2018 11
Fresenius SE & Co KGaA, Medical Devices Deals, 2012 to YTD 2018 12
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Fresenius Acquires Biosimilars Business from Merck for USD703 Million 17
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 19
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 20
Sound Inpatient Physicians Acquires Certain Assets from Inpatient Specialists 21
Fresenius Completes Acquisition Of 38 Hospitals And 11 Outpatient Facilities From Rhon-Klinikum 22
Sound Inpatient Physicians Acquires Certain Assets Of Inpatient Care Unified 24
Fresenius Kabi India To Acquire Manufacturing Unit Of Goa Formulations For US$37 Million 25
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 26
Fresenius Medical Care Elgin Raises US$3 Million In Venture Financing 27
Fresenius Medical Care Palatine Raises US$3 Million In Venture Financing 28
Fresenius Medical Care Raises US$5.5 Million In Venture Financing 29
Fresenius Vascular Care Raises US$0.3 Million In Venture Financing 30
Noro-Moseley Partners Acquires Minority Stake In Diabetes Care Group From Renal Care Group 31
Fresenius Medical Care Batavia Raises US$1.8 Million In Venture Financing 32
Fresenius Medical Care West Raises US$2.3 Million In Venture Financing 33
Fresenius Medical Care Enid Raises US$2.4 Million In Venture Financing 34
Spectral Medical Enters into Agreement with Fresenius Medical Care Deutschland 35
CytoSorbents Expands its Distribution Agreement with Fresenius Medical Care for CytoSorb Therapy 36
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 37
Otsuka Pharma Factory Enters Into Distribution Agreement With Fresenius Kabi Japan For HES Products 38
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 39
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 40
Provepharm Enters Into Distribution Agreement With Fresenius Kabi Pharma 41
Huons Enters Into Co-Promotion Agreement With Fresenius Kabi For Fresofol 42
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 43
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 44
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 45
Toray Industries Enters Into Licensing Agreement With Fresenius Medical Care For TRK-820 46
Humacyte to Raise USD150 Million in Equity Financing 47
Fresenius Plans Private Placement Of Shares For US$1.3 Billion 48
Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 49
Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 50
Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 51
Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 52
Fresenius Raises USD300 Million in Private Placement of Notes 53
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 54
Fresenius Increases Size Of Private Placement Of Notes Due 2024 For US$611.4 Million 55
Fresenius Completes Private Placement Of Notes Due 2019 For US$407.6 Million 56
Fresenius Completes Private Placement Of Notes Due 2021 For US$611.4 Million 57
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 58
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 60
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 61
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 62
Xellia Acquires Lyophilized Manufacturing Facility from Fresenius Kabi 63
Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 64
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 65
NewCo Pharma Acquires CFL from Fresenius Kabi 66
Sound Physicians Acquires Cogent Healthcare 67
Fresenius Medical Care Acquires National Cardiovascular 68
Fresenius Kabi Acquires Novafarma Industria Farmaceutica 69
Berenberg Acquires 5% Stake in Rhoen-Klinikum from Fresenius 70
Fresenius Medical Care Acquires MedSpring Urgent Care 72
Fresenius Medical Care to Acquire Majority Stake in Sound Inpatient Physicians for USD600 Million 73
Fresenius Kabi Acquires 51% Stake in Ethica Industri Farmasi From Soho Global Halthcare 74
Neopharm Acquires Biotech Arm Of Fresenius 75
Fresenius Kabi (Singapore) To Delist Its Indian Arm 77
Linde To Acquire Calea France From Fresenius Kabi 78
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 79
Fresenius Acquires 70% Stake In Huangshi Lishizhen Medicine Group Wuhan Xisu Pharma From Huangshi Lishizhen Medicine Group Wuhan Lishizhen Medicine 81
Fresenius Kabi Plans To Sell 15% Stake In Fresenius Kabi Oncology 82
Fresenius Medical Care Completes Acquisition Of Liberty Dialysis Holdings For US$1.7 Billion 83
Fresenius Medical Care Acquires Eastview Dialysis 85
Fresenius SE & Co KGaA, Key Competitors 86
Fresenius SE & Co KGaA, Key Employees 87
Fresenius SE & Co KGaA, Other Locations 88
Fresenius SE & Co KGaA, Subsidiaries 88

List Of Figures

List of Figures
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 9
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10
Fresenius SE & Co KGaA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11
Fresenius SE & Co KGaA, Medical Devices Deals, 2012 to YTD 2018 12

Fresenius Medical Care AG and Co KGaA (FMS) - Medical Equipment - Deals and Alliances Profile

Fresenius Medical Care AG & Co KGaA (Fresenius Medical), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It is one of the largest kidney dialysis

USD 250 View Report

Fresenius SE and Co KGaA (FRE) - Medical Equipment - Deals and Alliances Profile

Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available